Detalhe da pesquisa
1.
Impact of androgen suppression and zoledronic acid on bone mineral density and fractures in the Trans-Tasman Radiation Oncology Group (TROG) 03.04 Randomised Androgen Deprivation and Radiotherapy (RADAR) randomized controlled trial for locally advanced prostate cancer.
BJU Int;
114(3): 344-53, 2014 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24512527
2.
Androgen deprivation therapy for prostate cancer does not increase cardiovascular mortality in the long term.
Oncology;
82(1): 56-8, 2012.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22310055
3.
Serum procollagen 1 amino-terminal propeptide (P1NP) in prostate cancer: pitfalls of its use as an early surrogate marker for bone metastasis.
J Med Imaging Radiat Oncol;
58(4): 497-502, 2014 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24418365